ABSTRACT NUMBER: ESOC2026YS128 ACUTE MANAGEMENT AND OUTCOMES IN PATIENTS WITH SPONTANEOUS INTRACEREBRAL HAEMORRHAGE (ICH): INTERIM RESULTS FROM THE SITS-ICH STUDY

Abstract Background and aims Spontaneous intracerebral haemorrhage (ICH) is the most severe form of stroke. Previous trials have largely failed to improve functional outcomes. The INTERACT 3 trial demonstrated that implementing a care bundle protocol (CBP) focused on intensive blood pressure (BP) lowering and early physiological management can improve outcomes. We aimed to evaluate acute management and outcomes of CBP implementation in routine clinical practice. Methods This interim analysis of an ongoing, prospectively collected observational study used data from the international SITS-ICH Registry. Baseline characteristics, imaging data, acute management, and 3-month outcomes were recorded. Patients were classified as treated according to CBP or standard care (SC). Descriptive and multivariable mixed effects regression analyses were performed to adjust for baseline imbalances. Results Between January 2024 and October 2025, 1,989 patients from 58 centres across 23 countries were included. Median age was 69 years and median NIHSS score 9. CBP-treated patients had smaller ICH volumes (15 vs. 20 mL), higher baseline NIHSS (10 vs. 6), BP, glucose, and temperature, OAC use (17.5% vs. 12.1%), and received more haemostatic (27% vs. 7%) and surgical interventions (7% vs. 1%) compared with SC. Mortality (44% vs. 57%) and median modified Rankin Scale (mRS) scores (5 vs. 6) were lower in CBP-treated patients, but adjusted analyses showed no significant differences (death OR 0.81 [0.26–2.5]; ordinal mRS OR 0.86 [0.37–2.0]). In this interim analysis, CBP-treated patients had higher cardiovascular risk, with no significant adjusted 3-month outcome differences versus SC, although missing data and follow-up loss may have influenced results. Conflict of interest Marius Matusevicius: Nothing to disclose. Anand Dixit: Nothing to disclose. Jose Egido: Nothing to disclose. Daniel Strbian: Nothing to disclose. Sabrina Anticoli: Nothing to disclose. Niaz Ahmed: Nothing to disclose.

Authors

Institutions

Publication Details

Journal
European Stroke Journal
Published
2026-05-01
DOI
https://doi.org/10.1093/esj/aakag023.1210
Primary Topic
Intracerebral and Subarachnoid Hemorrhage Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ABSTRACT NUMBER: ESOC2026YS128 ACUTE MANAGEMENT AND OUTCOMES IN PATIENTS WITH SPONTANEOUS INTRACEREBRAL HAEMORRHAGE (ICH): INTERIM RESULTS FROM THE SITS-ICH STUDY

Niaz Ahmed, Marius Matusevicius, Senta Frol, Pasquale Scoppettuolo et al.
European Stroke Journal
Intracerebral and Subarachnoid Hemorrhage Research
article

ABSTRACT NUMBER: ESOC2026YS128 ACUTE MANAGEMENT AND OUTCOMES IN PATIENTS WITH SPONTANEOUS INTRACEREBRAL HAEMORRHAGE (ICH): INTERIM RESULTS FROM THE SITS-ICH STUDY

Niaz Ahmed, Marius Matusevicius, Senta Frol, Pasquale Scoppettuolo, Maria Mallia, К. Георгиев, Rachel Day, Tamer Roushdy
article en

Abstract

Abstract Background and aims Spontaneous intracerebral haemorrhage (ICH) is the most severe form of stroke. Previous trials have largely failed to improve functional outcomes. The INTERACT 3 trial demonstrated that implementing a care bundle protocol (CBP) focused on intensive blood pressure (BP) lowering and early physiological management can improve outcomes. We aimed to evaluate acute management and outcomes of CBP implementation in routine clinical practice. Methods This interim analysis of an ongoing, prospectively collected observational study used data from the international SITS-ICH Registry. Baseline characteristics, imaging data, acute management, and 3-month outcomes were recorded. Patients were classified as treated according to CBP or standard care (SC). Descriptive and multivariable mixed effects regression analyses were performed to adjust for baseline imbalances. Results Between January 2024 and October 2025, 1,989 patients from 58 centres across 23 countries were included. Median age was 69 years and median NIHSS score 9. CBP-treated patients had smaller ICH volumes (15 vs. 20 mL), higher baseline NIHSS (10 vs. 6), BP, glucose, and temperature, OAC use (17.5% vs. 12.1%), and received more haemostatic (27% vs. 7%) and surgical interventions (7% vs. 1%) compared with SC. Mortality (44% vs. 57%) and median modified Rankin Scale (mRS) scores (5 vs. 6) were lower in CBP-treated patients, but adjusted analyses showed no significant differences (death OR 0.81 [0.26–2.5]; ordinal mRS OR 0.86 [0.37–2.0]). In this interim analysis, CBP-treated patients had higher cardiovascular risk, with no significant adjusted 3-month outcome differences versus SC, although missing data and follow-up loss may have influenced results. Conflict of interest Marius Matusevicius: Nothing to disclose. Anand Dixit: Nothing to disclose. Jose Egido: Nothing to disclose. Daniel Strbian: Nothing to disclose. Sabrina Anticoli: Nothing to disclose. Niaz Ahmed: Nothing to disclose.

European Stroke JournalVol. 11(Supplement_1)
Ain Shams University (EG), Cliniques Universitaires Saint-Luc (BE), Karolinska University Hospital (SE), Medical University of Varna (BG), Mater Dei Hospital (MT), Northampton General Hospital (GB), Karolinska Institutet (SE), University Hospital St. Marina (BG)
Openalex Percentile: Top 10%
Intracerebral and Subarachnoid Hemorrhage Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.